The antitumor activity of the platinum complex D-17872 is associated with tumor cell differentiation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-03

AUTHORS

Hans Rainer Maurer, Christine Echarti, Rainer Voegeli, Jörg Pohl, Peter Hilgard

ABSTRACT

The novel cisplatin analogue D-17872 was studied for its anticancer activity using in vivo and in vitro preclinical models. The compound at the sublethal dose of 215 mg/kg (ca. 50% of the approximate LD50) induced no nephrotoxic effect strong enough to increase the blood urea level in rats. It had good in vivo antitumor efficacy against murine P388 (max. ILS: D-17872 132%, cisplatin 55%) and L1210 leukemia (max. ILS: D-17872 43%, cisplatin 38%), L5222 leukemia of the rat (max. ILS: D-17872 163%, cisplatin 163%) and murine B16 melanoma. Activity against P388 leukemia substantially exceeded that of cisplatin. Moreover, the M5076 reticulum cell sarcoma implanted into the subrenal capsule and the DMBA-induced mammary tumor of the rat were inhibited by D-17872 to a greater extent than by cisplatin (min. T/C: D-17872 -3%, cisplatin 11%). Using clonogenic microassays, D-17872 was active in vitro against a variety of human and rodent tumor cell lines, albeit at higher concentrations than cisplatin (IC50 values: D-17872 2.6-12.7 mumol/l, cisplatin 0.13-0.42 mumol/l). Apart from its cytotoxic action it was able to induce in vitro differentiation of the human HL-60 and K562 and of the murine M1-T22 cell lines, while cisplatin induced differentiation only in the HL-60 cell line. Thus D-17872 exhibited a pharmacological and toxicological profile different from that of the parent compound. The results suggest that induction of differentiation contributes to the antineoplastic efficacy of this novel cisplatin derivative. More... »

PAGES

123-128

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00685614

DOI

http://dx.doi.org/10.1007/bf00685614

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009878115

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8485806


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erythrocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ethylenediamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intraperitoneal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Monocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Freie Universit\u00e4t Berlin", 
          "id": "https://www.grid.ac/institutes/grid.14095.39", 
          "name": [
            "Institut f\u00fcr Pharmazie der Freien Universit\u00e4t Berlin, Kelchstrasse 31, W-1000, Berlin 41, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maurer", 
        "givenName": "Hans Rainer", 
        "id": "sg:person.01152357123.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152357123.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Freie Universit\u00e4t Berlin", 
          "id": "https://www.grid.ac/institutes/grid.14095.39", 
          "name": [
            "Institut f\u00fcr Pharmazie der Freien Universit\u00e4t Berlin, Kelchstrasse 31, W-1000, Berlin 41, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Echarti", 
        "givenName": "Christine", 
        "id": "sg:person.0737073211.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737073211.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Evonik (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420017.0", 
          "name": [
            "Department of Experimental Cancer Research, ASTA Medica AG, Weism\u00fcllerstrasse 45, W-6000, Frankfurt am Main 1, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voegeli", 
        "givenName": "Rainer", 
        "id": "sg:person.0633453775.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Evonik (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420017.0", 
          "name": [
            "Department of Experimental Cancer Research, ASTA Medica AG, Weism\u00fcllerstrasse 45, W-6000, Frankfurt am Main 1, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohl", 
        "givenName": "J\u00f6rg", 
        "id": "sg:person.0750105001.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Evonik (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420017.0", 
          "name": [
            "Department of Experimental Cancer Research, ASTA Medica AG, Weism\u00fcllerstrasse 45, W-6000, Frankfurt am Main 1, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "Peter", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/cber.19901230515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001086038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/222385a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001455608", 
          "https://doi.org/10.1038/222385a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jcp.1040810103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002242097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ajcp/55.3.283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004638475"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01058036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009275084", 
          "https://doi.org/10.1007/bf01058036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0079-6468(08)70421-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010819427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90262-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013236330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0305-7372(88)90031-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017935781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910200617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024257672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jcp.1040740303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031773974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90336-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00367775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039958983", 
          "https://doi.org/10.1007/bf00367775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0165-2478(84)90050-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046707656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0165-2478(84)90050-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046707656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00199911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049630706", 
          "https://doi.org/10.1007/bf00199911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00199911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049630706", 
          "https://doi.org/10.1007/bf00199911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910250208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051670208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077164433", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078864243", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079793523", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081763607", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081808884", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082053814", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-03", 
    "datePublishedReg": "1993-03-01", 
    "description": "The novel cisplatin analogue D-17872 was studied for its anticancer activity using in vivo and in vitro preclinical models. The compound at the sublethal dose of 215 mg/kg (ca. 50% of the approximate LD50) induced no nephrotoxic effect strong enough to increase the blood urea level in rats. It had good in vivo antitumor efficacy against murine P388 (max. ILS: D-17872 132%, cisplatin 55%) and L1210 leukemia (max. ILS: D-17872 43%, cisplatin 38%), L5222 leukemia of the rat (max. ILS: D-17872 163%, cisplatin 163%) and murine B16 melanoma. Activity against P388 leukemia substantially exceeded that of cisplatin. Moreover, the M5076 reticulum cell sarcoma implanted into the subrenal capsule and the DMBA-induced mammary tumor of the rat were inhibited by D-17872 to a greater extent than by cisplatin (min. T/C: D-17872 -3%, cisplatin 11%). Using clonogenic microassays, D-17872 was active in vitro against a variety of human and rodent tumor cell lines, albeit at higher concentrations than cisplatin (IC50 values: D-17872 2.6-12.7 mumol/l, cisplatin 0.13-0.42 mumol/l). Apart from its cytotoxic action it was able to induce in vitro differentiation of the human HL-60 and K562 and of the murine M1-T22 cell lines, while cisplatin induced differentiation only in the HL-60 cell line. Thus D-17872 exhibited a pharmacological and toxicological profile different from that of the parent compound. The results suggest that induction of differentiation contributes to the antineoplastic efficacy of this novel cisplatin derivative.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00685614", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "name": "The antitumor activity of the platinum complex D-17872 is associated with tumor cell differentiation", 
    "pagination": "123-128", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2f0ee1f63432951db17480d4ec3d54fa65bd9117f7cd97d4308a1082b9b8bc92"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8485806"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00685614"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009878115"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00685614", 
      "https://app.dimensions.ai/details/publication/pub.1009878115"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117109_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00685614"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00685614'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00685614'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00685614'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00685614'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      21 PREDICATES      67 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00685614 schema:about N08f6e4e9cf7347d79100601ff826d925
2 N241cb8ea9e3947d3b7980157e2731cbd
3 N27ddf4137e3949858d85af009580f19d
4 N2f3e57d2876843d3b4174c46c9fe14f3
5 N4e260c6fb922404195b4320fe5f9e5d0
6 N4ede5146e1324bb8b5c541a64b84d40d
7 N58c016a6db22466983c629e603f10d42
8 N58c27c2e97fb4e9f886c4a2bbfacc3da
9 N67034dfca8d04b37a505562e48a43452
10 N71824a308cef4869947a0643480cf56c
11 N7ad0e2adc1e24e6dae30007681c15eee
12 Na78870a5f85540649e1dbb8129bc288c
13 Nb737cbc478554d3cacb94159279f628b
14 Ndf5f7312152644be871a68bb214090fa
15 Ne504121beabc4ae9b48b49b21161ee7f
16 Nf407e9e89aaf4cd7891f6d6e2831b46e
17 Nf717966ff7ee496b94cf476c32ccc6e5
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N5b73f19cb9fb4c2ba2bf18c92b22c00c
21 schema:citation sg:pub.10.1007/bf00199911
22 sg:pub.10.1007/bf00367775
23 sg:pub.10.1007/bf01058036
24 sg:pub.10.1038/222385a0
25 https://app.dimensions.ai/details/publication/pub.1077164433
26 https://app.dimensions.ai/details/publication/pub.1078864243
27 https://app.dimensions.ai/details/publication/pub.1079793523
28 https://app.dimensions.ai/details/publication/pub.1081763607
29 https://app.dimensions.ai/details/publication/pub.1081808884
30 https://app.dimensions.ai/details/publication/pub.1082053814
31 https://doi.org/10.1002/cber.19901230515
32 https://doi.org/10.1002/ijc.2910200617
33 https://doi.org/10.1002/ijc.2910250208
34 https://doi.org/10.1002/jcp.1040740303
35 https://doi.org/10.1002/jcp.1040810103
36 https://doi.org/10.1016/0165-2478(84)90050-6
37 https://doi.org/10.1016/0277-5379(88)90262-3
38 https://doi.org/10.1016/0277-5379(88)90336-7
39 https://doi.org/10.1016/0305-7372(88)90031-x
40 https://doi.org/10.1016/s0079-6468(08)70421-1
41 https://doi.org/10.1093/ajcp/55.3.283
42 schema:datePublished 1993-03
43 schema:datePublishedReg 1993-03-01
44 schema:description The novel cisplatin analogue D-17872 was studied for its anticancer activity using in vivo and in vitro preclinical models. The compound at the sublethal dose of 215 mg/kg (ca. 50% of the approximate LD50) induced no nephrotoxic effect strong enough to increase the blood urea level in rats. It had good in vivo antitumor efficacy against murine P388 (max. ILS: D-17872 132%, cisplatin 55%) and L1210 leukemia (max. ILS: D-17872 43%, cisplatin 38%), L5222 leukemia of the rat (max. ILS: D-17872 163%, cisplatin 163%) and murine B16 melanoma. Activity against P388 leukemia substantially exceeded that of cisplatin. Moreover, the M5076 reticulum cell sarcoma implanted into the subrenal capsule and the DMBA-induced mammary tumor of the rat were inhibited by D-17872 to a greater extent than by cisplatin (min. T/C: D-17872 -3%, cisplatin 11%). Using clonogenic microassays, D-17872 was active in vitro against a variety of human and rodent tumor cell lines, albeit at higher concentrations than cisplatin (IC50 values: D-17872 2.6-12.7 mumol/l, cisplatin 0.13-0.42 mumol/l). Apart from its cytotoxic action it was able to induce in vitro differentiation of the human HL-60 and K562 and of the murine M1-T22 cell lines, while cisplatin induced differentiation only in the HL-60 cell line. Thus D-17872 exhibited a pharmacological and toxicological profile different from that of the parent compound. The results suggest that induction of differentiation contributes to the antineoplastic efficacy of this novel cisplatin derivative.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf Nacf33d03ea4f42d080853b20b52504db
49 Nf90328c0611040788455a7546388f23a
50 sg:journal.1088364
51 schema:name The antitumor activity of the platinum complex D-17872 is associated with tumor cell differentiation
52 schema:pagination 123-128
53 schema:productId N4a30eae4ce764f028cd313c627be6166
54 N6eedac9c972040ba8f91d7049733da9c
55 N6fc7c8a8a4a7424d862ffd031a510b65
56 N8d4132e5662343faa02fc204f9397842
57 Nbfecb3d3f55d463683d7c728f1c09340
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009878115
59 https://doi.org/10.1007/bf00685614
60 schema:sdDatePublished 2019-04-11T14:18
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N4cafe471a80a4b6c9f9815883ab389c1
63 schema:url http://link.springer.com/10.1007/BF00685614
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N08f6e4e9cf7347d79100601ff826d925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Female
69 rdf:type schema:DefinedTerm
70 N241cb8ea9e3947d3b7980157e2731cbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Cell Division
72 rdf:type schema:DefinedTerm
73 N27ddf4137e3949858d85af009580f19d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Erythrocytes
75 rdf:type schema:DefinedTerm
76 N2f3e57d2876843d3b4174c46c9fe14f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Mice
78 rdf:type schema:DefinedTerm
79 N308ebd2587ab45a1903bfb7f6c868a26 rdf:first sg:person.0633453775.54
80 rdf:rest Ne86158fd355449878e430695d670e33a
81 N4a30eae4ce764f028cd313c627be6166 schema:name dimensions_id
82 schema:value pub.1009878115
83 rdf:type schema:PropertyValue
84 N4cafe471a80a4b6c9f9815883ab389c1 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N4e260c6fb922404195b4320fe5f9e5d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Mice, Inbred C57BL
88 rdf:type schema:DefinedTerm
89 N4ede5146e1324bb8b5c541a64b84d40d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Tumor Cells, Cultured
91 rdf:type schema:DefinedTerm
92 N58c016a6db22466983c629e603f10d42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Animals
94 rdf:type schema:DefinedTerm
95 N58c27c2e97fb4e9f886c4a2bbfacc3da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Male
97 rdf:type schema:DefinedTerm
98 N5b73f19cb9fb4c2ba2bf18c92b22c00c rdf:first sg:person.01152357123.80
99 rdf:rest Na8fd12d0fc6f4da0b2edf42f5a70835b
100 N67034dfca8d04b37a505562e48a43452 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Monocytes
102 rdf:type schema:DefinedTerm
103 N6eedac9c972040ba8f91d7049733da9c schema:name doi
104 schema:value 10.1007/bf00685614
105 rdf:type schema:PropertyValue
106 N6fc7c8a8a4a7424d862ffd031a510b65 schema:name pubmed_id
107 schema:value 8485806
108 rdf:type schema:PropertyValue
109 N71824a308cef4869947a0643480cf56c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Antineoplastic Agents
111 rdf:type schema:DefinedTerm
112 N7ad0e2adc1e24e6dae30007681c15eee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Rats
114 rdf:type schema:DefinedTerm
115 N83231d1684c54d52a315aaa4a9da2f70 rdf:first sg:person.01023655171.21
116 rdf:rest rdf:nil
117 N8d4132e5662343faa02fc204f9397842 schema:name readcube_id
118 schema:value 2f0ee1f63432951db17480d4ec3d54fa65bd9117f7cd97d4308a1082b9b8bc92
119 rdf:type schema:PropertyValue
120 Na78870a5f85540649e1dbb8129bc288c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Cell Differentiation
122 rdf:type schema:DefinedTerm
123 Na8fd12d0fc6f4da0b2edf42f5a70835b rdf:first sg:person.0737073211.89
124 rdf:rest N308ebd2587ab45a1903bfb7f6c868a26
125 Nacf33d03ea4f42d080853b20b52504db schema:issueNumber 2
126 rdf:type schema:PublicationIssue
127 Nb737cbc478554d3cacb94159279f628b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Neoplasms, Experimental
129 rdf:type schema:DefinedTerm
130 Nbfecb3d3f55d463683d7c728f1c09340 schema:name nlm_unique_id
131 schema:value 7806519
132 rdf:type schema:PropertyValue
133 Ndf5f7312152644be871a68bb214090fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Cisplatin
135 rdf:type schema:DefinedTerm
136 Ne504121beabc4ae9b48b49b21161ee7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Ethylenediamines
138 rdf:type schema:DefinedTerm
139 Ne86158fd355449878e430695d670e33a rdf:first sg:person.0750105001.98
140 rdf:rest N83231d1684c54d52a315aaa4a9da2f70
141 Nf407e9e89aaf4cd7891f6d6e2831b46e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Rats, Sprague-Dawley
143 rdf:type schema:DefinedTerm
144 Nf717966ff7ee496b94cf476c32ccc6e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Injections, Intraperitoneal
146 rdf:type schema:DefinedTerm
147 Nf90328c0611040788455a7546388f23a schema:volumeNumber 32
148 rdf:type schema:PublicationVolume
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
153 schema:name Oncology and Carcinogenesis
154 rdf:type schema:DefinedTerm
155 sg:journal.1088364 schema:issn 0344-5704
156 1432-0843
157 schema:name Cancer Chemotherapy and Pharmacology
158 rdf:type schema:Periodical
159 sg:person.01023655171.21 schema:affiliation https://www.grid.ac/institutes/grid.420017.0
160 schema:familyName Hilgard
161 schema:givenName Peter
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
163 rdf:type schema:Person
164 sg:person.01152357123.80 schema:affiliation https://www.grid.ac/institutes/grid.14095.39
165 schema:familyName Maurer
166 schema:givenName Hans Rainer
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152357123.80
168 rdf:type schema:Person
169 sg:person.0633453775.54 schema:affiliation https://www.grid.ac/institutes/grid.420017.0
170 schema:familyName Voegeli
171 schema:givenName Rainer
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54
173 rdf:type schema:Person
174 sg:person.0737073211.89 schema:affiliation https://www.grid.ac/institutes/grid.14095.39
175 schema:familyName Echarti
176 schema:givenName Christine
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737073211.89
178 rdf:type schema:Person
179 sg:person.0750105001.98 schema:affiliation https://www.grid.ac/institutes/grid.420017.0
180 schema:familyName Pohl
181 schema:givenName Jörg
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750105001.98
183 rdf:type schema:Person
184 sg:pub.10.1007/bf00199911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049630706
185 https://doi.org/10.1007/bf00199911
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/bf00367775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039958983
188 https://doi.org/10.1007/bf00367775
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/bf01058036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009275084
191 https://doi.org/10.1007/bf01058036
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/222385a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001455608
194 https://doi.org/10.1038/222385a0
195 rdf:type schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1077164433 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1078864243 schema:CreativeWork
198 https://app.dimensions.ai/details/publication/pub.1079793523 schema:CreativeWork
199 https://app.dimensions.ai/details/publication/pub.1081763607 schema:CreativeWork
200 https://app.dimensions.ai/details/publication/pub.1081808884 schema:CreativeWork
201 https://app.dimensions.ai/details/publication/pub.1082053814 schema:CreativeWork
202 https://doi.org/10.1002/cber.19901230515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001086038
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1002/ijc.2910200617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024257672
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/ijc.2910250208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051670208
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1002/jcp.1040740303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031773974
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1002/jcp.1040810103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002242097
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/0165-2478(84)90050-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046707656
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/0277-5379(88)90262-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013236330
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/0277-5379(88)90336-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699947
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/0305-7372(88)90031-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017935781
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s0079-6468(08)70421-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010819427
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1093/ajcp/55.3.283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004638475
223 rdf:type schema:CreativeWork
224 https://www.grid.ac/institutes/grid.14095.39 schema:alternateName Freie Universität Berlin
225 schema:name Institut für Pharmazie der Freien Universität Berlin, Kelchstrasse 31, W-1000, Berlin 41, Germany
226 rdf:type schema:Organization
227 https://www.grid.ac/institutes/grid.420017.0 schema:alternateName Evonik (Germany)
228 schema:name Department of Experimental Cancer Research, ASTA Medica AG, Weismüllerstrasse 45, W-6000, Frankfurt am Main 1, Germany
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...